Mrinalika Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-06-2024
- Paid Up Capital ₹ 0.10 M
as on 01-06-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit 108.93%
(FY 2020)
- Ebitda -465.84%
(FY 2020)
- Net Worth 38.10%
(FY 2020)
- Total Assets 1191.23%
(FY 2020)
About Mrinalika Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Mishra, Ramesh Mishra, and Amit Mishra serve as directors at the Company.
- CIN/LLPIN
U24239UP2018PTC109578
- Company No.
109578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Azamgarh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mrinalika Pharma Private Limited offer?
Mrinalika Pharma Private Limited offers a wide range of products and services, including Bathroom Accessories, Soap & Sanitizer Dispenser, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Mrinalika Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Mishra  | Director | 24-Dec-2019 | Current |
| Ramesh Mishra | Director | 24-Oct-2018 | Current |
| Amit Mishra | Director | 24-Oct-2018 | Current |
Financial Performance of Mrinalika Pharma.
Mrinalika Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 108.93% increase in profit. The company's net worth Soared by an impressive increase of 38.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mrinalika Pharma?
Unlock access to Mrinalika Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mrinalika Services Private LimitedActive 3 years 10 monthsRamesh Mishra and Amit Mishra are mutual person
- Santripti Enterprises Manufacturing Private LimitedActive 4 years 10 months
Amit Mishra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mrinalika Pharma?
Unlock and access historical data on people associated with Mrinalika Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mrinalika Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mrinalika Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
